Topical N-acetylcysteine for lamellar ichthyosis

Lancet

Volumn 354, Issue 9193, 1999, Pages 1880-

  Redondo, Pedro ^a   Bauzá, Ana ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ETRETIN; UREA DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; KERATINOCYTE; LAMELLAR ICHTHYOSIS; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

EID: 0345685437     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)04245-2     Document Type: Article

References (5)

1. Bonanomi L., Gazzaniga A. Toxicological, pharmacokinetic and metabolic studies on acetylcysteine. Eur J Respir Dis. 111:1980;45-51.
2. Redondo P., García-Foncillas J., Okroujnov I., Bandrés E. α-MSH regulates interleukin-10 expression by human keratinocytes. Arch Dermatol Res. 290:1998;425-428.
3. Vandersteen P.R., Muller S.A. Lamellar ichthyosis. An enzyme histochemical, light and electron microscopic study Arch Dermatol. 106:1972;694-701.
4. Kim J.A., Baker D.G., Hahn S.S., Goodchild N.T., Constable W.C. Topical use of N-acetylcysteine for reduction of skin reaction to radiation therapy. Semin Oncol. 10:1983;86-92.
5. Sekharam M., Trotti A., Cunnick J.M., Wu J. Suppression of fibroblast cell cycle progression in G1 phase by N-acetylcysteine. Toxicol Appl Pharmacol. 149:1998;210-216.